Healthcare Leader
In India JENMED PILLS PRIVATE LIMITED (JPPL) is a leading Indian pharmaceutical company founded in 2023 by experienced technocrats with strong regulatory expertise and a commitment to excellence. Our journey began in 2016 as Jenerx Pharma Solution, based in Bhonthapally, Hyderabad, Telangana.
In our pursuit of growth and innovation, JPPL has recently commissioned a new, state-of-the-art manufacturing facility in Veliminedu Village, Nalgonda District, Telangana. This export-oriented plant is designed to meet the highest international standards and cater to the global pharmaceutical market.
Key features of our facility:
1. Current Production Capacity: 50-80 metric tons per month
2. Expansion Potential: Up to 100 metric tons per month
3. Focus: Export-oriented production
4. Quality Assurance: Adherence to international regulatory standards
At JPPL, we combine cutting-edge technology with regulatory expertise to deliver high-quality pharmaceutical pellets to our global clientele. Our team's dedication to innovation and quality positions us as a trusted partner in the pharmaceutical industry.
As we continue to grow, we remain committed to our core values of excellence, integrity, and customer satisfaction, driving us to meet the evolving needs of the global healthcare sector.
Our Team and Product Excellence
At JENMED PILLS PRIVATE LIMITED, we pride ourselves on our dedicated workforce and commitment to product quality.
Our Team:
We maintain a robust workforce of over 50 employees, comprising both full-time equivalents (FTEs) and casual staff. This diverse team brings a wealth of expertise to our operations, ensuring efficiency and innovation across all departments.
Product Portfolio:
Our extensive range of value-added pharmaceutical products sets us apart in the industry. We are committed to delivering excellence through:
1. Bioequivalence Studies: We conduct rigorous bioequivalence studies for our products, ensuring:
- Clinical effectiveness
- Safety assurance
- Compliance with international standards
2. Comparative Studies: Our products undergo thorough comparative analyses with innovator drugs, demonstrating:
- Equivalent efficacy
- Consistent quality
- Competitive edge in the market
By combining cutting-edge research with stringent quality control, we guarantee that our pharmaceutical pellets meet the highest standards of safety and efficacy. Our dedication to scientific rigor and product excellence positions us as a trusted partner in the global pharmaceutical landscape.
To be a leading global pharmaceutical innovator, developing diverse, cost-effective dosage forms for various diseases in highly regulated markets. We aim to improve global health and become the partner of choice for leading pharmaceutical companies worldwide.
To be a global leader in innovative generic formulations, delivering high-quality, cost-effective medications across therapeutic segments while ensuring optimal safety and efficacy through advanced technology and unwavering commitment to regulatory standards.
At JENMED PILLS PRIVATE LIMITED, our success is built on the foundation of our exceptional core team. Our professionals bring together a diverse range of skills and experiences, ensuring excellence across all aspects of pharmaceutical development and production.
Key Areas of Expertise:
1. Process Development & New Product Innovation
2. Analytical Method Development and Validation
3. Regulatory Affairs: DMF/Dossier Preparation and Submission
4. Manufacturing Operations
5. Quality Control (QC)
6. Quality Assurance (QA)
Team Composition:
- Highly qualified pharmaceutical professionals
- Well-trained and experienced industry experts
- Diverse technical backgrounds
- Strong legal team
- Accomplished board of advisors
This multidisciplinary approach allows us to navigate the complex landscape of pharmaceutical development, ensuring that our products meet the highest standards of quality, safety, and regulatory compliance.
By combining cutting-edge expertise with a commitment to innovation, our core team drives JPPL's mission to deliver superior generic formulations to the global market.